Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-31

Clinical Trial Update: Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma [Phase 3]

View source ↗

Summary

The update reports completion of a Phase 3 trial evaluating the efficacy and safety of a fixed-dose budesonide/formoterol inhalation in uncontrolled asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol (budesonide/formoterol)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED